New lab-made antibody matches IVIG effectiveness at lower doses in mice

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently FDA-approved for four diseases but widely prescribed off-label to treat more than 80 additional ones because it’s often the only medicine that has any impact on these conditions.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup